Log in to save to my catalogue

Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors

Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2516608064

Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors

About this item

Full title

Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors

Publisher

London: Nature Publishing Group UK

Journal title

Nature reviews. Nephrology, 2021-05, Vol.17 (5), p.319-334

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Diabetic kidney disease is the leading cause of kidney failure worldwide; in the USA, it accounts for over 50% of individuals entering dialysis or transplant programmes. Unlike other complications of diabetes, the prevalence of diabetic kidney disease has failed to decline over the past 30 years. Hyperglycaemia is the primary aetiological factor re...

Alternative Titles

Full title

Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2516608064

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2516608064

Other Identifiers

ISSN

1759-5061

E-ISSN

1759-507X

DOI

10.1038/s41581-021-00393-8

How to access this item